Wide Ranks

MIRA

MIRA Pharmaceuticals, Inc.

1.27

Top Statistics
Market Cap 21 M Forward PE -2.24 Revenue Growth 0.00 %
Current Ratio 3.68 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 2 M Total Cash Per Share 0.1910 Total Debt
Total Debt To Equity Current Ratio 3.68 Book Value Per Share 0.2960
All Measures
Short Ratio 47.00 % Message Board Id finmb_1793899557 Shares Short Prior Month 440246
Return On Equity -7.49 City Miami Uuid a71f8b50-3996-3ccd-98e2-c993481fee2f
Previous Close 1.28 First Trade Date Epoch Utc 1 B Book Value 0.2960
Volume 162302 Price To Book 4.29 Fifty Two Week Low 0.5100
Total Cash Per Share 0.1910 Shares Short Previous Month Date 1 B Target Median Price 11.00
Max Age 86400 Recommendation Mean 1.00 Sand P52 Week Change 0.3133
Target Mean Price 12.08 Net Income To Common -12784287 Short Percent Of Float 0.1030
Implied Shares Outstanding 16 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 458770 Average Volume10days 458770 Total Cash 2 M
Next Fiscal Year End 1 B Held Percent Insiders 0.2721 Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 1.28
Target Low Price 7.50 Gmt Off Set Milliseconds -18000000 Fifty Day Average 1.34
Open 1.30 Free Cashflow -4450804 State FL
Dividend Yield 0.00 % Return On Assets -1.78 Time Zone Short Name EST
Trailing Eps -0.5500 Day Low 1.25 Address1 1200 Brickell Avenue
Shares Outstanding 16 M Price Hint 4 Target High Price 17.75
Website https://mirapharmaceuticals.com 52 Week Change -0.6423 Average Volume 1 M
Forward Eps -0.4900 Recommendation Key strong_buy Compensation As Of Epoch Date 1 B
Quick Ratio 354.50 % Is_sp_500 False Regular Market Day High 1.30
Profit Margins 0.00 % Fifty Two Week High 5.01 Day High 1.30
Shares Short 1 M Regular Market Open 1.30 Industry Key drug-manufacturers-general
Earnings Growth 0.00 % Revenue Growth 0.00 % Shares Percent Shares Out 0.0776
Operating Cashflow -4709749 Currency USD Time Zone Full Name America/New_York
Market Cap 21 M Is_nasdaq_100 False Zip 32183
Quote Type EQUITY Industry Drug Manufacturers - General Long Name MIRA Pharmaceuticals, Inc.
Regular Market Day Low 1.25 Held Percent Institutions 0.0596 Current Price 1.27
Address2 Suite 1950 #1183 Financial Currency USD Current Ratio 3.68
Industry Disp Drug Manufacturers - General Number Of Analyst Opinions 3 Country United States
Float Shares 9 M Two Hundred Day Average 1.23 Enterprise Value 20 M
Forward PE -2.24 Regular Market Volume 162302 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders.

The company holds exclusive U.

S.

, Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder.

In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Miami, Florida.